Evidence map›Paper›PMID 39256552›Full record

ArticleProstate cancer and prostatic diseases2025

Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure.

Silvia Secco, Alberto Olivero, Mattia Longoni, Paolo Dell'Oglio, Stefano Tappero, Edoardo Dibilio, Tommaso Saccucci, Giampaolo Siena, Aldo Massimo Bocciardi, Antonio Galfano and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Best of 2025 in prostate cancer and prostatic diseases.Prostate cancer and prostatic diseases · 2026
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Silvia SeccoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. silvia.secco@ospedaleniguarda.it.ORCID http://orcid.org/0000-0002-4953-0091
Alberto OliveroDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Mattia LongoniUnit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID http://orcid.org/0000-0002-2613-2306
Paolo Dell'OglioDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID http://orcid.org/0000-0002-2771-2919
Stefano TapperoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID http://orcid.org/0000-0001-9712-2685
Edoardo DibilioDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Tommaso SaccucciDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Giampaolo SienaUnit of Oncologic Minimally Invasive Urology and Andrology, Careggi University Hospital, Florence, Italy.ORCID http://orcid.org/0000-0002-8919-0175
Aldo Massimo BocciardiDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Antonio GalfanoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID http://orcid.org/0000-0002-2656-5531
Luca CindoloDepartment of Urology, Villa Stuart Private Hospital, Rome, Italy.ORCID http://orcid.org/0000-0002-0712-2719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesEndorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning. SUBJECTS/

methodsOf 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS).

resultsNo differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA.

conclusionsSC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.

Indexed as

AnesthesiaAnesthesia, LocalProstatic HyperplasiaTransurethral Resection of ProstateAgedAged, 80 and overHumansMaleMiddle AgedPain Measurement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.